Legal Opinion

In re Cymbalta (Duloxetine) Products Liability Litigation (No. II)

United States Judicial Panel on Multidistrict Litigation

Decided October 9, 2015No. MDL No. 2662PublishedCited by 1 opinion

1Opinion of the Court

ORDER DENYING TRANSFER

Sarah S. Vance, Chair

Before the Panel: * Plaintiffs in two actions (Beard and Courtney) pending in the Southern District of Indiana move under 28 U.S.C. § 1407 to centralize 41 actions in that district.1 The actions, which are listed on the attached Schedule A, are pending in a total of 22 districts. Plaintiffs in the other 39 actions did not respond to the motion. Common defendant Eli Lilly and Company (Lilly) opposes centralization.

I

The complaints in these 41 personal injury actions are substantially similar. Plaintiffs allege that they suffered a wide variety of…

2Cases cited3 opinions

  1. In Re Eli Lilly & Co.(cephalexin Monohydrate)United States Judicial Panel on Multidistrict Litigation · 1978
  2. In re Plavix Marketing, Sales Practices & Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2013
  3. In re Cymbalta (Duloxetine) Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2014

3Cited by1 opinion

  1. In re Helicopter Crash Near Savannah, Georgia, on January 15, 2014United States Judicial Panel on Multidistrict Litigation · 2016

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API